Pursuant to Regulation 33 and 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we would like to inform you that the Board of Directors in its meeting held on Thursday, February 14, 2019, commenced at 02:00 p.m. at 25th Floor, One Horizon Centre, DLF Phase - V, Golf Course Road, Gurugram 122002 have, inter alia, considered and taken on record the Unaudited Financial Results for the Quarter ended December 31, 2018. We are enclosing a copy of the Unaudited Financial Results for the Quarter ended December 31, 2018 along with the Limited Review Report, issued by the Auditors for the review done by them, for your records.

Pdf Link: Glaxosmithkline Consumer Healthcare Ltd. - Unaudited Financial Results For Quarter Ended December 31, 2018

Source : BSE - www.bseindia.com